BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 38321439)

  • 21. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of breast cancer two years after a benign biopsy depends on the mammographic feature prompting recall.
    Vernet-Tomás M; Louro J; Román M; Saladié F; Posso M; Prieto M; Vázquez I; Baré M; Peñalva L; Vidal C; Bargalló X; Sánchez M; Ferrer J; A Espinàs J; Quintana MJ; Rodríguez-Arana A; Castells X;
    Maturitas; 2021 Feb; 144():53-59. PubMed ID: 33358209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integration of Handheld Ultrasound or Automated Breast Ultrasound among Women with Negative Mammographic Screening Findings: A Multi-center Population-based Study in China.
    Ren W; Yan H; Zhao X; Jia M; Zhang S; Zhang J; Li Z; Ming L; Zhang Y; Li H; He L; Li X; Cheng X; Yue L; Zhou W; Qiao Y; Zhao F
    Acad Radiol; 2023 Sep; 30 Suppl 2():S114-S126. PubMed ID: 37003874
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tomosynthesis with synthesised two-dimensional mammography yields higher cancer detection compared to digital mammography alone, also in dense breasts and in younger women: A systematic review and meta-analysis.
    Heywang-Köbrunner SH; Jänsch A; Hacker A; Weinand S; Vogelmann T
    Eur J Radiol; 2022 Jul; 152():110324. PubMed ID: 35576720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [A comparative study of breast cancer mass screening and opportunistic screening in Chinese women].
    Shen SJ; Xu YL; Zhou YD; Ren GS; Jiang J; Jiang HC; Zhang J; Li B; Jin F; Li YP; Xie FM; Shi Y; Wang ZD; Sun M; Yuan SH; Yu JJ; Chen Y; Sun Q
    Zhonghua Wai Ke Za Zhi; 2021 Feb; 59(2):109-115. PubMed ID: 33378802
    [No Abstract]   [Full Text] [Related]  

  • 27. Mammography in combination with breast ultrasonography versus mammography for breast cancer screening in women at average risk.
    Gartlehner G; Thaler K; Chapman A; Kaminski-Hartenthaler A; Berzaczy D; Van Noord MG; Helbich TH
    Cochrane Database Syst Rev; 2013 Apr; 2013(4):CD009632. PubMed ID: 23633376
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Breast cancer screening in urban Beijing, 2014-2019].
    Yang L; Zhang X; Liu S; Li HC; Zhang Q; Wang N; Ji JF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Sep; 54(9):974-980. PubMed ID: 32907288
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness and cost-effectiveness of double reading in digital mammography screening: A systematic review and meta-analysis.
    Posso M; Puig T; Carles M; Rué M; Canelo-Aybar C; Bonfill X
    Eur J Radiol; 2017 Nov; 96():40-49. PubMed ID: 29103474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
    Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
    Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Cross-Sectional Observational Study to Compare the Role of Ultrasound with Mammography in Women Identified at High Risk for Breast Cancer in a Population in China.
    An P; Zhong S; Zhang R; Hou X; Xi R; Wang Y
    Med Sci Monit; 2020 Jun; 26():e919777. PubMed ID: 32576809
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy study.
    Lång K; Josefsson V; Larsson AM; Larsson S; Högberg C; Sartor H; Hofvind S; Andersson I; Rosso A
    Lancet Oncol; 2023 Aug; 24(8):936-944. PubMed ID: 37541274
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Economic evaluation on breast cancer screening in mainland China: a systematic review].
    Wang L; Shi JF; Huang HY; Zhu J; Li J; Fang Y; Dai M
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Dec; 37(12):1662-1669. PubMed ID: 27998418
    [No Abstract]   [Full Text] [Related]  

  • 35. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Artificial intelligence (AI) for breast cancer screening: BreastScreen population-based cohort study of cancer detection.
    Marinovich ML; Wylie E; Lotter W; Lund H; Waddell A; Madeley C; Pereira G; Houssami N
    EBioMedicine; 2023 Apr; 90():104498. PubMed ID: 36863255
    [TBL] [Abstract][Full Text] [Related]  

  • 37. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Short-term outcomes of screening mammography using computer-aided detection: a population-based study of medicare enrollees.
    Fenton JJ; Xing G; Elmore JG; Bang H; Chen SL; Lindfors KK; Baldwin LM
    Ann Intern Med; 2013 Apr; 158(8):580-7. PubMed ID: 23588746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Age-specific interval breast cancers in New South Wales and meta-analysis of studies of women aged 40-49 years.
    Taylor R; Page A; Bampton D; Estoesta J; Rickard M
    J Med Screen; 2004; 11(4):199-206. PubMed ID: 15563775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Breast Cancer Detection Rate, Incidence, Prevalence and Interval Cancer-related Mammography Screening Times among Thai Women.
    Sripaiboonkij N; Thinkamrop B; Promthet S; Kannawat C; Tangcharoensathien V; Ansusing T; Rattanamongkolgul S
    Asian Pac J Cancer Prev; 2016; 17(8):4137-41. PubMed ID: 27644674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.